Jay Matushak Sells 1,860 Shares of NeueHealth, Inc. (NYSE:NEUE) Stock

NeueHealth, Inc. (NYSE:NEUEGet Free Report) CFO Jay Matushak sold 1,860 shares of the business’s stock in a transaction that occurred on Friday, March 7th. The stock was sold at an average price of $7.19, for a total value of $13,373.40. Following the transaction, the chief financial officer now owns 22,227 shares in the company, valued at approximately $159,812.13. This represents a 7.72 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website.

Jay Matushak also recently made the following trade(s):

  • On Monday, January 6th, Jay Matushak sold 4,970 shares of NeueHealth stock. The stock was sold at an average price of $7.33, for a total value of $36,430.10.

NeueHealth Price Performance

Shares of NeueHealth stock opened at $6.77 on Thursday. The stock has a market cap of $56.09 million, a P/E ratio of -0.13 and a beta of 0.56. The stock’s 50 day simple moving average is $7.32 and its 200-day simple moving average is $5.99. NeueHealth, Inc. has a 1-year low of $3.79 and a 1-year high of $7.73.

Analyst Upgrades and Downgrades

Separately, Royal Bank of Canada lowered their target price on NeueHealth from $8.00 to $7.00 and set a “sector perform” rating on the stock in a report on Monday, December 9th.

Get Our Latest Report on NEUE

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently made changes to their positions in the stock. Virtu Financial LLC purchased a new stake in shares of NeueHealth during the 4th quarter valued at approximately $76,000. Northern Trust Corp raised its position in shares of NeueHealth by 66.8% during the 4th quarter. Northern Trust Corp now owns 32,644 shares of the company’s stock valued at $242,000 after buying an additional 13,074 shares during the period. Finally, Partners Group Holding AG purchased a new stake in shares of NeueHealth during the 3rd quarter valued at approximately $463,000. 63.88% of the stock is currently owned by institutional investors and hedge funds.

About NeueHealth

(Get Free Report)

NeueHealth, Inc, a healthcare company, provides various healthcare services for health consumers, providers, and payors in the United States. It operates through two segments: NeueCare and NeueSolutions. The NeueCare segment delivers healthcare services to ACA marketplace, medicare, and medicaid through owned and affiliated clinics.

Further Reading

Insider Buying and Selling by Quarter for NeueHealth (NYSE:NEUE)

Receive News & Ratings for NeueHealth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NeueHealth and related companies with MarketBeat.com's FREE daily email newsletter.